Within the Anti-Hair Regrowth Agent Ingredients segmentation, application is the primary driver of revenue allocation. The market is divided into three application categories: topical, oral, and injectable. Topical formulations—creams, gels, foams, and serums—represent the largest share, accounting for roughly 65 % of total sales. Their dominance stems from direct delivery to the scalp, low systemic exposure, and regulatory ease, which encourages both legacy and emerging players to launch products. Oral agents, comprising tablets, capsules, and nutraceutical blends, capture about 25 % of the market. They are valued for convenience and systemic mechanisms that influence hormonal pathways, yet they face stricter safety scrutiny that moderates growth. Injectable solutions, including micro‑injections of growth factors or platelet‑rich plasma adjuncts, occupy the remaining 10 %. Although niche, this segment shows higher average price points and rapid adoption in clinical settings, contributing disproportionately to profitability despite its modest volume.